Collegium Pharmaceutical Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Vikram Karnani
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 4.3yrs |
| Board average tenure | 10.3yrs |
Recent management updates
Recent updates
Shareholders Can Be Confident That Collegium Pharmaceutical's (NASDAQ:COLL) Earnings Are High Quality
Nov 14
Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?
Oct 28Collegium Pharmaceutical: Diversifying And Growing
Aug 09Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Price Is Right But Growth Is Lacking
Jul 24Collegium Pharmaceutical (NASDAQ:COLL) Seems To Use Debt Quite Sensibly
Jun 05Collegium Pharmaceutical: Some Positives From Its Quarterly 'Miss'
May 13It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package
May 10Collegium Pharmaceutical Q4: The Beat Goes On
Feb 26These 4 Measures Indicate That Collegium Pharmaceutical (NASDAQ:COLL) Is Using Debt Reasonably Well
Feb 24There's No Escaping Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) Muted Revenues
Jan 05Here's Why Collegium Pharmaceutical (NASDAQ:COLL) Can Manage Its Debt Responsibly
Nov 12Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Aug 09Is Collegium Pharmaceutical (NASDAQ:COLL) A Risky Investment?
Mar 10Is Collegium Pharmaceutical (NASDAQ:COLL) Using Too Much Debt?
Oct 18Collegium Pharmaceutical (NASDAQ:COLL) Has A Somewhat Strained Balance Sheet
Jun 24Collegium Pharmaceutical: Oversold And Cheap
Jun 12CEO
Vikram Karnani (49 yo)
no data
Tenure
Mr. Vikram Karnani is CEO, President & Director of Collegium Pharmaceutical, Inc. since November 12, 2024. Mr. Karnani was Executive Vice President and President, Global Commercial Operations and Medical A...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 21.1yrs | US$330.61k | 0.087% $ 839.5k | |
| Executive VP & CFO | 3.5yrs | US$2.73m | 0.061% $ 590.6k | |
| Executive VP | 6.7yrs | US$2.87m | 0% $ 0 | |
| Executive VP & Chief Commercial Officer | 6.3yrs | US$2.61m | 0% $ 0 | |
| Executive VP & Chief Medical Officer | 2.7yrs | US$2.04m | 0% $ 0 | |
| CEO, President & Director | no data | no data | no data | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive Vice President of Strategy & Corporate Development | 5.2yrs | no data | no data | |
| Head of Technical Operations | 3.1yrs | no data | no data |
4.3yrs
Average Tenure
50.5yo
Average Age
Experienced Management: COLL's management team is considered experienced (4.3 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Co-Founder & Chairman | 21.1yrs | US$330.61k | 0.087% $ 839.5k | |
| CEO, President & Director | no data | no data | no data | |
| Independent Director | 10.8yrs | US$298.61k | 0.22% $ 2.1m | |
| Independent Director | 9.8yrs | US$299.61k | 0.0073% $ 70.5k | |
| Lead Independent Director | 12.3yrs | US$322.61k | 0.079% $ 762.2k | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Independent Director | 8.4yrs | US$289.61k | 0.12% $ 1.1m | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data | |
| Scientific Advisor | no data | no data | no data |
10.3yrs
Average Tenure
68.5yo
Average Age
Experienced Board: COLL's board of directors are seasoned and experienced ( 10.3 years average tenure).